Skip to main content
TipRanks
Go Ultimate75% OFF

Argent Biopharma (H5O0) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Argent Biopharma has a market cap or net worth of EUR 1.52M. The enterprise value is EUR 12.72M.

Market Cap
EUR 1.52M
Enterprise Value
EUR 12.72M

Share Statistics

Argent Biopharma has 117,859,580 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
117,859,580
Owned by Insiders
5.94%
Owned by Institutions
―

Financial Efficiency

Argent Biopharma’s return on equity (ROE) is 0.82 and return on invested capital (ROIC) is -5166.99%.

Return on Equity (ROE)
0.82
Return on Assets (ROA)
-5.95
Return on Invested Capital (ROIC)
-5166.99%
Return on Capital Employed (ROCE)
1.02
Revenue Per Employee
32.24K
Profits Per Employee
-1.54M
Employee Count
5
Asset Turnover
0.12
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Argent Biopharma is -0.20. Argent Biopharma’s PEG ratio is -0.00.

PE Ratio
-0.20
PS Ratio
15.36
PB Ratio
-0.22
Price to FCF
-0.46
Price to Operating Cash Flow
-0.38
PEG Ratio
-0.00

Income Statement

In the last 12 months, Argent Biopharma had revenue of 161.19K and earned -7.71M in profits. Earnings per share was -0.09.

Revenue
161.19K
Gross Profit
-204.21K
Operating Income
-7.39M
Pretax Income
-7.71M
Net Income
-7.71M
EBITDA
-7.23M
Earnings Per Share (EPS)
-0.09

Cash Flow

In the last 12 months, operating cash flow was -5.33M and capital expenditures -2,421, giving a free cash flow of -5.33M billion.

Operating Cash Flow
-5.33M
Free Cash Flow
-5.33M
Free Cash Flow per Share
-0.05

Dividends & Yields

Argent Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-215.38%
Earnings Yield
-449.59%

Stock Price Statistics

Beta
-2.72
52-Week Price Change
-70.59%
50-Day Moving Average
0.01
200-Day Moving Average
0.01
Relative Strength Index (RSI)
47.86
Average Volume (3m)
3,715

Important Dates

Argent Biopharma upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 28, 2026
Next Earnings Date
Mar 03, 2027
Ex-Dividend Date
―

Financial Position

Argent Biopharma as a current ratio of 0.05, with Debt / Equity ratio of -101.51%

Current Ratio
0.05
Quick Ratio
0.05
Debt to Market Cap
3.05
Net Debt to EBITDA
-1.31
Interest Coverage Ratio
-219.33

Taxes

In the past 12 months, Argent Biopharma has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Argent Biopharma EV to EBITDA ratio is -1.38, with an EV/FCF ratio of -2.24.

EV to Sales
73.96
EV to EBITDA
-1.38
EV to Free Cash Flow
-2.24
EV to Operating Cash Flow
-2.24

Balance Sheet

Argent Biopharma has EUR 141.46K in cash and marketable securities with EUR 9.59M in debt, giving a net cash position of -EUR 9.45M billion.

Cash & Marketable Securities
EUR 141.46K
Total Debt
EUR 9.59M
Net Cash
-EUR 9.45M
Net Cash Per Share
-EUR 0.08
Tangible Book Value Per Share
-EUR 0.10

Margins

Gross margin is -126.69%, with operating margin of -4586.90%, and net profit margin of -5693.88%.

Gross Margin
-126.69%
Operating Margin
-4586.90%
Pretax Margin
-4783.36%
Net Profit Margin
-5693.88%
EBITDA Margin
-5365.48%
EBIT Margin
-5516.60%

Analyst Forecast

The average price target for Argent Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
10.33%
EPS Growth Forecast
76.52%

Scores

Smart Score
7
AI Score
―